These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance]. Jiao ZY, Gou CZ, Cao N, Li YM. Ai Zheng; 2005 Jul; 24(7):880-4. PubMed ID: 16004820 [Abstract] [Full Text] [Related]
45. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, Nagasue N. Cancer; 1998 Apr 01; 82(7):1225-32. PubMed ID: 9529012 [Abstract] [Full Text] [Related]
47. Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis. Zhang Y, Wang C, Mizukami H, Itoh H, Kusama M, Ozawa K, Jinbu Y. J Exp Clin Cancer Res; 2006 Sep 01; 25(3):417-23. PubMed ID: 17167983 [Abstract] [Full Text] [Related]
48. Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters. Lentsch EJ, Goudy S, Sosnowski J, Major S, Bumpous JM. Laryngoscope; 2006 Mar 01; 116(3):397-400. PubMed ID: 16540897 [Abstract] [Full Text] [Related]
49. The matrix metalloproteinase system in oral squamous cell carcinoma. Baker EA, Leaper DJ, Hayter JP, Dickenson AJ. Br J Oral Maxillofac Surg; 2006 Dec 01; 44(6):482-6. PubMed ID: 16338034 [Abstract] [Full Text] [Related]
51. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study. Dong P, Li X, Yu Z, Lu G. J Laryngol Otol; 2007 Dec 01; 121(12):1177-83. PubMed ID: 17888194 [Abstract] [Full Text] [Related]
52. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer. Byun JH, Lee MA, Roh SY, Shim BY, Hong SH, Ko YH, Ko SJ, Woo IS, Kang JH, Hong YS, Lee KS, Lee AW, Park GS, Lee KY. Jpn J Clin Oncol; 2006 May 01; 36(5):263-8. PubMed ID: 16735371 [Abstract] [Full Text] [Related]
54. The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis. Herrmann E, Bögemann M, Bierer S, Eltze E, Toma MI, Köpke T, Hertle L, Wülfing C. Oncol Rep; 2007 Jul 01; 18(1):133-8. PubMed ID: 17549358 [Abstract] [Full Text] [Related]
55. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. Erdem NF, Carlson ER, Gerard DA, Ichiki AT. J Oral Maxillofac Surg; 2007 Sep 01; 65(9):1725-33. PubMed ID: 17719389 [Abstract] [Full Text] [Related]
56. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. Kim SH, Cho NH, Kim K, Lee JS, Koo BS, Kim JH, Chang JH, Choi EC. J Surg Oncol; 2006 Mar 15; 93(4):330-7. PubMed ID: 16496371 [Abstract] [Full Text] [Related]
57. [Neovascularization around tumors in esophageal carcinoma]. Samejima N, Ikeda K, Hirata S, Fujii K. Gan No Rinsho; 1985 Oct 15; 31(13):1673-80. PubMed ID: 2416964 [Abstract] [Full Text] [Related]
59. Expression of carbohydrate antigens in human esophageal squamous cell carcinoma: prognostic application and its diagnostic implications. Faried A, Kimura H, Faried LS, Usman N, Miyazaki T, Kato H, Yazawa S, Kuwano H. Ann Surg Oncol; 2007 Feb 15; 14(2):960-7. PubMed ID: 17094023 [Abstract] [Full Text] [Related]
60. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients. Hoshino I, Matsubara H, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Ochiai T. Oncol Rep; 2007 Oct 15; 18(4):867-71. PubMed ID: 17786348 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]